ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Funding Opportunities
National Institutes of HealthHHS-Nih11

Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)

Funder: National Institutes of Health

Posted Nov 3, 2026·Last checked Nov 22, 2026·open

AGENCY

National Institutes of Health

PROGRAM

Discretionary

AMOUNT

—

CLOSES

Nov 16, 2029

Description

The purpose of the Notice of Funding Opportunity (NOFO) is to support the analytical and clinical validation of molecular, cellular, and imaging biomarkers and assays for cancer detection, diagnosis, prognosis, monitoring, prediction of response or resistance to treatment, cancer prevention and control, as well as pharmacodynamic markers and markers of toxicity. Utilizing either a phased UH2/UH3 or a standalone UH3 mechanism, funding will facilitate laboratory optimization and clinical validation of assays that work on human samples and address a clearly defined cancer-related clinical need within a well-specified intended use.

Eligibility

County governments; Special district governments; Small businesses; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); City or township governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; For profit organizations other than small businesses; Independent school districts; Public housing authorities/Indian housing authorities; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education

Contact

National Institutes of Health

NCICDPNOFO@mail.nih.gov

301-402-2541

Additional details

Department
HHS-Nih11
Funding instrument
Cooperative Agreement
Cost sharing required
No
Archived
Jan 15, 2030

Opportunity number: PAR-28-042

Quote this number when you contact the agency or apply.